Company profile
CDT Equity Inc.
NASDAQ: CDT · Healthcare · Biotechnology
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH 48DQ —GM —SS 19
v0.1 · 35/100 weight · pillars only
↑ Piotroski F, Altman-Z · ↓ return on assets, listing tenure
Methodology →Revenue TTM
$696.4M
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$39.2M
Employees
4
as of 2026-08-25
Market cap
$1.2M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$39.2M-$39.2M2025
Operating income-$36.8M-$36.8M2025
Total assets$5.7M$5.7M2025
Liabilities$12.8M$12.8M2025
Equity-$7.2M-$7.2M2025
Revenue by segment
Filed disclosures · FY2024
By product
Automation Solutions100%
By geography
UNITED STATES57%
Other Countries28%
CANADA7%
GERMANY5%
CHINA4%
The read
What is CDT Equity Inc.’s financial profile?
CDT Equity Inc. earned -$39.2M in FY2025 net income.
Peers · Healthcare
Somatic Systems, Inc.——North American Cannabis Holdings, Inc.——Mid-Atlantic Home Health Network, Inc.——Dermata Therapeutics, Inc.——Tocca Life Holdings Inc——PharmaCom BioVet, Inc.——Neighbors
Collier →Key facts
CEOAndrew Regan
SectorHealthcare
IndustryBiotechnology
HeadquartersNaples, FL
ExchangeNASDAQ: CDT
Employees4
IPO date2022-03-28
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.